InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by AMGEN INC. Insider active across 3 companies, notably BeiGene, Ltd.. Cumulatively, 6 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €112.6m. History available since 10 September 2021. The latest transaction was filed on 19 September 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
1,764,705 shares@ US$17.00100.0% of flowCommon StockSEC:0001610717-23-000289:1
Ideal exit: 15 Jun 2024 (T+270)
33,603,948 sharesCommon StockSEC:0001610717-23-000289:0
3,206,281 sharesCommon StockSEC:0000899243-22-001666
3,206,281 sharesCommon StockSEC:0000899243-22-001666:0
165,529 shares@ US$302.06150.13% mcap50.0% of flowAmerican Depositary SharesSEC:0000899243-21-035731:0
Ideal exit: 7 Jun 2022 (T+270)
165,529 shares@ US$302.061550.0% of flowAmerican Depositary SharesSEC:0000899243-21-035731
Ideal exit: 7 Jun 2022 (T+270)
6 of 6 declarations
About AMGEN INC
AMGEN INC is a declarant linked to Neumora Therapeutics, Inc., where it is identified as a 10% Owner, as well as to Vigil Neuroscience, Inc. and BeiGene, Ltd. It has 6 filings in total, and across the 6 sampled filings, acquisitions amount to EUR 112644379, with no sales, between 2021-09-13 and 2023-09-19.
